Bharat Biotech says awaiting CDSCO approval to launch Covaxin for children
Hyderabad, Oct 12: After getting approval from Subject Expert Committee (SEC) for Covaxin to be used for children in the 2 to 18 years age group with certain conditions, Bharat Biotech on Tuesday said they are awaiting further regulatory approvals from
Source: India News, India Breaking News, Latest news headlines in India – Oneindia News